On the morning of October 20, 2018, seven Niuyun and other five leading shengjia representative enterprises signed a strategic cooperation agreement with Shanghai Chen Tianqiao Institute of Brain Diseases, which will make full use of their respective advantageous resources to jointly support the institute’s brain science research.
Mr. Lv Guihua, president of Qiniuyun, attended the event on behalf of the company and signed a strategic cooperation agreement with Professor MAO Ying, vice president of Huashan Hospital, Director of Shanghai Chen Tianqiao Institute of Brain Diseases and Director of Neurosurgery Committee of Chinese Medical Association.
At the scene, Mr. Lv guihua had in-depth communication with many experts in the field, such as neurology and psychiatry experts and professors from Huashan Hospital and Shanghai Mental Health Center, on medical big data processing, human visual recognition research, speech recognition of psychiatric patients, VR/AR game treatment of brain diseases, etc. The cooperation between industry, learning and research in artificial intelligence is further discussed.
As a non-profit and public welfare research institution, Shanghai Chen Tianqiao International Institute of Brain Diseases will invest 50 million RMB in the first phase, with a total investment of 500 million RMB. Mr. Chen Tianqiao is the director of the Institute, and the board members include Professor Zhou Liangfu, academician of the Chinese Academy of Engineering and director of the Neurosurgery Department of Huashan Hospital, and Professor MAO Ying, vice president of Huashan Hospital and a well-known neuromedicine expert in China, who also serves as the director. The institute aims to create a platform for gathering outstanding Chinese neurologist and psychiatrist scholars to carry out basic and clinical research cooperation, international exchange and achievement transformation of brain diseases. It is understood that the institute’s current funding projects have included brain tumors, Alzheimer’s disease, Parkinson’s disease, depression and other diseases research and treatment.
As the leading enterprise cloud computing service provider with visual intelligence and data intelligence as the core, and also the most characteristic intelligent video cloud service provider in China, Qiuniuyun will help Shanghai Chen Tianqiao Institute of Brain Diseases to process massive brain data by relying on the massive data processing capacity accumulated over the years. From data storage backup to big data analysis to provide brain science research and results analysis. At the same time, qiniuyun’s domestic leading deep learning RESEARCH and development team will also assist in high-tech research and development of intelligent recognition and directional analysis in medical images, and realize a series of intelligent diagnosis and treatment research work such as intelligent analysis of brain diseases and auxiliary diagnosis and treatment of brain diseases.
Qiniu Cloud vision intelligent system diagram
To help customers shorten the distance from ideas to products has always been the vision of Seven Niuyun. The strategic cooperation between Seven Niuyun and Shanghai Chen Tianqiao Institute of Brain Diseases will promote seven Niuyun to bring advanced cloud computing, big data and artificial intelligence technology to the medical industry, and create more value to accelerate the development of China’s medical and health care.